Amanullah A M, Kiat H, Friedman J D, Berman D S
Department of Medicine, Nuclear Cardiology, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
J Am Coll Cardiol. 1996 Mar 15;27(4):803-9. doi: 10.1016/0735-1097(95)00550-1.
This study sought to assess the diagnostic efficacy of adenosine technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) in a consecutive series of female patients.
The utility of adenosine myocardial perfusion SPECT for the detection of coronary artery disease is not well defined in women because most studies have described a predominantly male population with a high prevalence of coronary artery disease.
Of the 201 consecutive female patients in the study group who had undergone adenosine Tc-99m sestamibi myocardial perfusion SPECT, 130 had coronary angiography within 2 months of the nuclear test, and the other 71 had a low likelihood (<10%, mean [+/-SD] 5 +/- 3%) of coronary artery disease. The SPECT protocol used separate acquisition of rest thallium-201 and adenosine Tc-99m sestamibi and was visually analyzed in 20 segments with a semiquantitative five-point scoring system (0=normal; 4=absent uptake).
The normalcy rate in patients with a low likelihood of coronary artery disease was 93% (66 of 71). Among the catheterized group, the overall sensitivity, specificity and predictive accuracy of adenosine sestamibi SPECT for detecting coronary artery disease (> or = to 50% diameter stenosis) were 93% (87 of 94), 78% (28 of 36) and 88% (115 of 130), respectively. In the 103 patients without a prior myocardial infarction, the sensitivity, specificity and predictive accuracy were 91% (61 of 67), 78% (28 of 36) and 86% (89 of 103), respectively, for detecting > or = to 50% diameter stenosis. Of particular interest, the sensitivity and specificity were as high in patients with nonanginal symptoms (93% and 69%, respectively) as in patients with angina (92% and 83%, respectively, p=NS). The sensitivity and specificity among patients with a relatively low (<25%), intermediate (between 25% and 75%) or high prescan likelihood of coronary artery disease (>75%) were similar: 82% and 82%, 93% and 73%, and 95% and 100%, respectively. The sensitivity and specificity for detecting individual diseased vessels (> or = to 50% diameter stenosis) were, respectively, 76% and 81% for the left anterior descending coronary artery, 44% and 90% for the left circumflex coronary artery and 75% and 77% for the right coronary artery.
Adenosine Tc-99m sestamibi SPECT is an efficient protocol with high sensitivity and specificity for the detection of coronary artery disease in women irrespective of presenting symptoms or pretest likelihood of coronary artery disease and a high normalcy rate. These findings are of particular clinical relevance because chest pain, anginal or otherwise, has been shown to be a frequent but a less specific marker for coronary artery disease among female patients.
本研究旨在评估99m锝-甲氧基异丁基异腈心肌灌注单光子发射计算机断层扫描(SPECT)对一系列连续女性患者的诊断效能。
腺苷心肌灌注SPECT在检测女性冠状动脉疾病中的效用尚未明确,因为大多数研究描述的主要是冠状动脉疾病患病率高的男性人群。
研究组中201例连续接受腺苷99m锝-甲氧基异丁基异腈心肌灌注SPECT检查的女性患者,130例在核素检查后2个月内接受了冠状动脉造影,另外71例冠状动脉疾病可能性低(<10%,平均[±标准差]5±3%)。SPECT方案采用静息铊-201和腺苷99m锝-甲氧基异丁基异腈分别采集,并采用半定量五点评分系统(0=正常;4=无摄取)对20个节段进行视觉分析。
冠状动脉疾病可能性低的患者正常率为93%(71例中的66例)。在导管检查组中,腺苷甲氧基异丁基异腈SPECT检测冠状动脉疾病(直径狭窄≥50%)的总体敏感性、特异性和预测准确性分别为93%(94例中的87例)、78%(36例中的28例)和88%(130例中的115例)。在103例无既往心肌梗死的患者中,检测直径狭窄≥50%的敏感性、特异性和预测准确性分别为91%(67例中的61例)、78%(36例中的28例)和86%(103例中的89例)。特别值得注意的是,非心绞痛症状患者(分别为93%和69%)的敏感性和特异性与心绞痛患者(分别为92%和83%,p=无显著性差异)一样高。冠状动脉疾病预扫描可能性相对低(<25%)、中等(25%至75%之间)或高(>75%)的患者中,敏感性和特异性相似:分别为82%和82%、93%和73%、95%和100%。检测单个病变血管(直径狭窄≥50%)的敏感性和特异性,左前降支冠状动脉分别为76%和81%,左旋支冠状动脉分别为44%和90%,右冠状动脉分别为75%和77%。
99m锝-甲氧基异丁基异腈SPECT是一种有效的方案,对女性冠状动脉疾病的检测具有高敏感性和特异性,无论其症状表现或冠状动脉疾病的预测试验可能性如何,且正常率高。这些发现具有特殊的临床意义,因为胸痛,无论是否为心绞痛,已被证明是女性患者中冠状动脉疾病常见但特异性较低的标志物。